Internal Medicine, Endocrinology, Diabetes, & Metabolism · Indianapolis, IN
NPI
1619931441
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
541 Clinical Dr # 365
Indianapolis, IN, 46202
Phone (317) 274-0550
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,089
223 services
Medicare patients, 2024
90
Average age 74
Drug cost, 2024
$1.0M
308 prescriptions
Company payments, 2025
$13K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael J Econs was code 99214 (office e&m - established), 95 times for 70 patients. In total Michael J Econs billed 223 services in 6 codes, and Medicare paid $9,089.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 95 | 70 | $60.19 | $5,718 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 94 | 70 | $11.20 | $1,053 |
| 99213 Office E&M - Established | Facility | 14 | 14 | $43.22 | $605 |
| 99215 Office E&M - Established | Facility | 13 | 12 | $97.96 | $1,273 |
By year: 2022 $11K for 183 services; 2023 $12K for 180 services; 2024 $9,089 for 223 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael J Econs prescribed most often to Medicare patients was Alendronate Sodium, with 95 prescriptions and refills. In total Michael J Econs wrote 308 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alendronate Sodium Generic | 95 | 258 | 32 | $580 |
| Tymlos Abaloparatide | 45 | 49 | Under 11 | $135K |
| Levothyroxine Sodium Generic | 38 | 110 | 12 | $562 |
| Crysvita Burosumab-Twza | 33 | 33 | Under 11 | $844K |
| Cinacalcet Hcl Generic | 21 | 33 | Under 11 | $7,785 |
| Calcitriol Generic | 17 | 50 | Under 11 | $824 |
Brand drugs: - claims; generic drugs: 190 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael J Econs $13K ($12K in general payments such as food, travel and fees and $1,500 for research) from 3 companies. The largest payer was Kyowa Kirin, Inc. with $8,845.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.